Cytokinetics Inc (CYTK)
US$ 30.485-2.63%
Price Chart
Key Statistics
Market Cap
$ 3.87B
P/E Ratio
0.00
Revenue (TTM)
$ 19.22M
Volume
1.26M
52W High
$ 61.38
52W Low
$ 29.31
Dividend Yield
0.00%
Beta
0.59
Technicals
50-Day MA
35.9034
200-Day MA
46.7969
52 Week High
61.38
52 Week Low
29.31
About CYTK
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating di.
Employees
498
Headquarters
South San Francisco, CA
CEO
Mr. Robert I. Blum
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg